BARCLAYS PLC

Barclays reports Q2 earnings that beat estimates, boosting capital‑to‑RWA, equity‑trading profits and a new buy‑back program—strong growth, solid returns.

Barclays’ July 2026 exempt principal trader filings reveal modest, diversified holdings across property, tech and insurance, sparking scrutiny over conflict of interest and the need for greater transparency.

Barclays PLC’s July 2026 FCA compliance filing confirms regulatory adherence while signaling no immediate strategic changes, underscoring its risk‑managed stability.

Barclays’ recent Takeover Code and Irish Panel filings reveal a diversified mid‑cap strategy—long and short positions plus derivatives—showing how the bank balances risk, boosts liquidity, and signals potential takeovers. Explore how this impacts ma…

Barclays PLC tightens U.S. equity exposure, warns of volatility, and discloses U.K. holdings to balance risk and capitalize on market retrenchments.

Barclays PLC insider sales, derivative exposure, and sectoral impact: a detailed analysis of executive trading, ESG‑linked bets, and regulatory risks.

Barclays boosts its voting‑rights stake in LANXESS to 5 %, crossing the 3 % threshold, as part of a strategic European equity realignment amid market volatility and new EU disclosure rules.

Barclays PLC’s May 2026 equity disclosures reveal 3‑4% stakes in Intertek and NCC Group, plus smaller positions in energy, food, property and finance—offering insights into governance influence, market impact and diversification strategy.

Barclays’ May 2026 8‑3 filings show a balanced 2–3% stake and short in Intertek & JTC, plus cash‑settled swaps, underscoring its hedged, diversified strategy across tech, construction, and more.

Barclays PLC’s May 2026 disclosure reveals a diversified, regulator‑compliant mix of equity and derivative positions across 15+ listed companies, highlighting strategic adjustments in healthcare, energy, real‑estate, and tech sectors to optimize ris…